4-[4-hydroxy-4-(tetrahydro-2H-pyran-4-yl)cyclohexyl]-6-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-7-propyl[1,2,4]triazolo[1,5-a]pyrimidin-5(4H)-one 分子结构式
HCID136063725

4-[4-hydroxy-4-(tetrahydro-2H-pyran-4-yl)cyclohexyl]-6-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-7-propyl[1,2,4]triazolo[1,5-a]pyrimidin-5(4H)-one

3-[2-[4-[[4-[4-hydroxy-4-(oxan-4-yl)cyclohexyl]-5-oxo-7-propyl-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl]methyl]phenyl]phenyl]-4H-1,2,4-oxadiazol-5-one

C34H38N6O5610.7 g/mol

IDENTITY

结构与身份

标准SMILES
CCCc1c(Cc2ccc(-c3ccccc3-c3noc(=O)[nH]3)cc2)c(=O)n(C2CCC(O)(C3CCOCC3)CC2)c2ncnn12
InChIKey
DLCUAUIIOWJGFM-UHFFFAOYSA-N
分子式
C34H38N6O5
平均分子量
610.7 g/mol
单同位素质量
610.29036833

COMPUTED

结构计算性质

已同步
XLogP
5
极性表面积
131 Ų
氢键供体
2
氢键受体
8
可旋转键
8
重原子
45
形式电荷
0
复杂度
1,150

ALIASES

名称与别名

共 3 条
SCHEMBL1374115DLCUAUIIOWJGFM-UHFFFAOYSA-N4-[4-hydroxy-4-(tetrahydro-2H-pyran-4-yl)cyclohexyl]-6-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-7-propyl[1,2,4]triazolo[1,5-a]pyrimidin-5(4H)-one

REACTIONS

参与反应

5
HRID 520124 反应方程式

uspto-grants-2015_08 · 10.6084/m9.figshare.5104873.v1 · US09115136B2

查看
HRID 1412832 反应方程式

uspto-grants-2014_12 · 10.6084/m9.figshare.5104873.v1 · US08921379B2

查看
HRID 1689086 反应方程式

uspto-grants-2012_04 · 10.6084/m9.figshare.5104873.v1 · US08148383B2

查看
HRID 2048860 反应方程式

uspto-grants-2013_11 · 10.6084/m9.figshare.5104873.v1 · US08592431B2

查看
HRID 2063054 反应方程式

uspto-grants-2012_10 · 10.6084/m9.figshare.5104873.v1 · US08283353B2

查看